UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13
or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(Commission
File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code) |
Registrant’s telephone number, including
area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01 Other Events
On September 28, 2023, Helius Medical Technologies, Inc. (the “Company”) issued a press release announcing that Wolters Kluwer Health – Medi-Span® has assigned universal product code numbers (“UPCs”) to the Company’s Portable Neuromodulation Stimulator (“PoNS®”) system and mouthpiece. The PoNS system has been assigned the Global Trade Item Number (“GTIN”) of 00864288000462, and the PoNS mouthpiece has been assigned the GTIN of 00864288000431.
A press release issued by the Company on September 28, 2023 regarding the assignment of these UPCs is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) | Exhibits. |
The following exhibits are filed as part of this Report:
No. | Description | |
99.1 | Press Release dated September 28, 2023 | |
104 | Cover Page Interactive Data File (embedded within Inline XBRL document). |
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Helius Medical Technologies, Inc. | ||
Date: September 28, 2023 | By: | /s/ Jeffrey S. Mathiesen |
| Jeffrey S. Mathiesen | |
| Chief Financial Officer, Treasurer and Secretary |